Profilo
Eric D.
Lynch is the founder of Sound Pharmaceuticals, Inc. which was founded in 2002.
He held the titles of Board Member, Vice President & Research Director from 2009 to 2010.
Dr. Lynch's former jobs include being a Research Director at Otogene and a Principal at the University of Washington.
Dr. Lynch received a doctorate degree from the University of California, Berkeley.
Precedenti posizioni note di Eric D. Lynch
| Società | Posizione | Fine |
|---|---|---|
Sound Pharmaceuticals, Inc.
 Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Fondatore | 01/12/2017 |
| Otogene | Direttore Tecnico/Scientifico/R&S | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Formazione di Eric D. Lynch
| University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Sound Pharmaceuticals, Inc.
Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Health Technology |
| Otogene |
- Borsa valori
- Insiders
- Eric D. Lynch
